Home › CytomX IPO Could Pop, But Long-Term Returns Are Uncertain
 

Keywords :   


CytomX IPO Could Pop, But Long-Term Returns Are Uncertain

2015-10-07 21:20:52| Biotech - Topix.net

CytomX Therapeutics expects to raise $100 million in its upcoming IPO. Based in South San Francisco, California, CytomX Therapeutics is a biopharmaceutical company focused on developing treatments for cancer.

Tags: pop returns ipo uncertain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
More »